1. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial. (July 2019) Authors: Reck, Martin; Schenker, Michael; Lee, Ki Hyeong; Provencio, Mariano; Nishio, Makoto; Lesniewski-Kmak, Krzysztof; Sangha, Randeep; Ahmed, Samreen; Raimbourg, Judith; Feeney, Kynan; Corre, Romain; Franke, Fabio Andre; Richardet, Eduardo; Penrod, John R.; Yuan, Yong; Nathan, Faith E.; Bhagavatheeswa... Journal: European journal of cancer Issue: Volume 116(2019) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. Issue 7 (July 2019) Authors: Scagliotti, Giorgio V; Gaafar, Rabab; Nowak, Anna K; Nakano, Takashi; van Meerbeeck, Jan; Popat, Sanjay; Vogelzang, Nicholas J; Grosso, Federica; Aboelhassan, Rasha; Jakopovic, Marko; Ceresoli, Giovanni L; Taylor, Paul; Orlandi, Francisco; Fennell, Dean A; Novello, Silvia; Scherpereel, Arnaud; Ku... Journal: Lancet Issue: Volume 7:Issue 7(2019) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations. Issue 4 (April 2016) Authors: Klughammer, Barbara; Brugger, Wolfram; Cappuzzo, Federico; Ciuleanu, Tudor; Mok, Tony; Reck, Martin; Tan, Eng Huat; Delmar, Paul; Klingelschmitt, Gaëlle; Yin, Anny‐Yue; Spleiss, Olivia; Wu, Lin; Shames, David S. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. (April 2018) Authors: Levy, Antonin; Faivre-Finn, Corinne; Hasan, Baktiar; De Maio, Eleonora; Berghoff, Anna S.; Girard, Nicolas; Greillier, Laurent; Lantuéjoul, Sylvie; O'Brien, Mary; Reck, Martin; Dingemans, Anne-Marie C.; Novello, Silvia; Berghmans, Thierry; Besse, Benjamin; Hendriks, Lizza Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes with nivolumab in advanced solid cancers. (November 2018) Authors: Tykodi, Scott S.; Schadendorf, Dirk; Cella, David; Reck, Martin; Harrington, Kevin; Wagner, Samuel; Shaw, James W. Journal: Cancer treatment reviews Issue: Volume 70(2018) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers. (22nd August 2019) Authors: Rossi, Alessandra; Voigtlaender, Minna; Klose, Hans; Schlüter, Hartmut; Schön, Gerhard; Loges, Sonja; Paolini, Moreno; Bokemeyer, Carsten; Reck, Martin; Tarro, Giulio; Binder, Mascha Other Names: Gupta Shalini Guest Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune checkpoint blockade in small cell lung cancer. (November 2019) Authors: Tay, Rebecca Y.; Heigener, David; Reck, Martin; Califano, Raffaele Journal: Lung cancer Issue: Volume 137(2019) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterizing death acceptance among patients with cancer. Issue 4 (10th March 2019) Authors: Philipp, Rebecca; Mehnert, Anja; Lo, Chris; Müller, Volkmar; Reck, Martin; Vehling, Sigrun Journal: Psycho-oncology Issue: Volume 28:Issue 4(2019) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74–77]. (December 2019) Authors: Putora, Paul Martin; Glatzer, Markus; De Ruysscher, Dirk; Faivre-Finn, Corinne; Belderbos, José; Besse, Benjamin; Blackhall, Fiona; Califano, Raffaele; Cappuzzo, Federico; de Marinis, Filippo; Dziadiuszko, Rafal; Felip, Enriqueta; Früh, Martin; Garrido, Pilar; Le Pechoux, Cecile; McDonald, Fiona;... Journal: Radiotherapy and oncology Issue: Volume 141(2019) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019) Authors: Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗